The publications on this site are part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Informa
Skip to Page Content

Heart Valves
One of the immutable rules of device company development is that success takes many paths. No matter the clinical space a company start out in, it is bound to encounter unexpected obstacles....

The EBI Special Reports Innovation Series helps minimize these unexpected obstacles by carefully hand-picking the most relevant, thought-provoking, and analytical articles for our readers in a given clinical space. The Heart Valves report contains six articles selected from START-UP, IN VIVO, and Medtech Insight that speak to the ongoing research and development efforts that are tapping into the unmet need for effective non-surgical options for both aortic and mitral valve disease.

Articles include:

  • New Access Devices Create Gateway To Interventional Structural Heart Disease (START-UP)
  • Percutaneous Mitral Valve Therapy: The Next Decade (START-UP)
  • Micro Interventional Devices: Creating a Tool Box For Structural Heart Disease (IN VIVO)
  • Symentis: Well-Positioned Next-Generation TAVI Player (IN VIVO)
  • As TAVI Advances, Adjunctive Devices Multiply (Medtech Insight)
  • Edwards: Transcatheter Valve Leader Proves You Can
    Go Home Again (IN VIVO)

Let us be your strategic partner as you receive insider information on innovative new products, profiles on emerging competitors, and the market numbers that could affect your bottom line. Download your copy today and stay ahead of the competition.


No refunds will be given for reports.
Questions? Contact Kristy Kennedy at 480-985-9512 or k.kennedy@elsevier.com.